Africa: Malaria Vaccine Price Cut Set to Protect 7 Million More Children By 2030

UNICEF secures agreement to cut malaria vaccine costs

The new agreement will significantly improve access to and affordability of the R21/Matrix-M malaria vaccines, helping to protect more children from one of the world's deadliest diseases, according to UNICEF.

Africa: Malaria Vaccine Price Cut Set to Protect 7 Million More Children By 2030

Vaccine alliance Gavi and children's agency UNICEF have struck a new pricing deal that will sharply cut the cost of a key malaria vaccine and make it possible to protect nearly seven million additional children by 2030, the agencies announced on Sunday.

Gavi and UNICEF announce equitable pricing deal for malaria vaccine to protect 7 million more children by end of decade

GENEVA/New York/Copenhagen, Nov 25 – Gavi, the Vaccine Alliance and UNICEF today announced a new agreement that will make the R21/Matrix-MTM malaria vaccines significantly more accessible and affordable, paving the way to protect more children from one of the world’s deadliest diseases. The deal, backed by Gavi and executed by UNICEF, is expected to generate up to US$ 90 million in savings for Gavi and countries, equivalent to more than 30 milli…

Malaria vaccine prices cut to expand coverage

Gavi, the Vaccine Alliance, and UNICEF have lowered the price of the new R21/Matrix-M malaria vaccine, a decision expected to expand access and protect close to seven million children across Africa over the next five years. ALSO READ: Why Rwanda did not apply for latest malaria vaccine The agreement, supported by the International Finance Facility for Immunisation (IFFIm), will allow countries to secure millions of additional doses at a more aff…

Gavi, UNICEF Secure Major Price Cut for India-Made Malaria Vaccine

Global vaccine alliance Gavi and UNICEF have announced a significant price reduction for the R21 malaria vaccine, manufactured by the Serum Institute of India. The cost will drop by 25% — from around $4 to $2.99 per dose — within a year, enabling wider access amid declining international aid. The move is expected to bolster child immunization efforts in some of the world’s poorest regions. According to Gavi, the reduced price will generate an es…